JPRN-jRCT1011200008进行中（未招募）4 期
Comparison of the effect on glycemic control and quality of life between semaglutide and, liraglutide or dulaglutide in patients with type 2 diabetes -prospective randomized controlled trial- - Semaglutide study
omoto Hiroshi0 个研究点目标入组 100 人开始时间: 2020年11月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 90age old（—）
- 性别
- All
入选标准
- •1) HbA1c 6.0-10.0%
- •2) BMI >= 22 kg/m2
- •3) patients who were treated with liraglutide or dulaglutide at least for 12 weeks
- •4) written informed consent
排除标准
- •1) patients with type 2 diabetes who were treated with GLP-1 receptor agonist other than liraglutide or dulaglutide, 2) history of anaphylaxis of semaglutide, 3) unstable retinopathy, 4) severe hepatic dysfunction or renal dysfunction, 5) severe ketosis, diabetic coma, 6) severe infection, surgery, serious trauma, 7) pregnancy,8) patients who are inadequate to enter this study due to the other reasons by physician's judgments
研究者
相似试验
已完成
4 期
Study for the effects of semaglutide on glycemic control and quality of life in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000042369Hokkaido University Hospital110
招募中
4 期
Study for the effects of imeglimin on glycemic control in patients with type 2 diabetestype 2 diabetesJPRN-jRCT1011220005omoto Hiroshi70
招募中
4 期
Study for the effects of once-daily semaglutid on glycemic control in patients with type 2 diabetes (SWITCH SEMA-2 study)JPRN-jRCT1011210032omoto Hiroshi172
已完成
4 期
Study for the effects of oral semaglutide on glycemic control in patients with type 2 diabetesJPRN-UMIN000045270Hokkaido University Hospital172
尚未招募
不适用
Compare the add-on effects in glycemic control and durability of sitagliptin and alfa-glucosidase inhibitor uncontrolled with metformin monotherapy.typw2 diabetesJPRN-UMIN000006630Saitama social insurance hospital100